Completed PHASE2 INTERVENTIONAL NCT00233922

Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant

Sponsor: National Healthcare Group, Singapore

Conditions Orbital Fractures Orbital Trauma

Updated 5 times since 2017 Last updated: May 12, 2008 Started: Jul 31, 2004 Completion: Jul 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Orbital Fractures and Orbital Trauma and is currently completed. National Healthcare Group, Singapore leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Healthcare Group, Singapore
National University Hospital, Singapore

Data source: National University Hospital, Singapore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore